142 related articles for article (PubMed ID: 36274297)
1. Cytoreductive Surgery for Primary Central Nervous System Lymphoma: Is it time to consider extent of resection?
Singhal S; Antoniou E; Kwan E; Gregory G; Lai LT
J Clin Neurosci; 2022 Dec; 106():110-116. PubMed ID: 36274297
[TBL] [Abstract][Full Text] [Related]
2. Surgical Resection for Primary Central Nervous System Lymphoma: A Systematic Review.
Labak CM; Holdhoff M; Bettegowda C; Gallia GL; Lim M; Weingart JD; Mukherjee D
World Neurosurg; 2019 Jun; 126():e1436-e1448. PubMed ID: 30904794
[TBL] [Abstract][Full Text] [Related]
3. The role of surgical resection in primary central nervous system lymphoma: a single-center retrospective analysis of 70 patients.
Wu S; Wang J; Liu W; Hu F; Zhao K; Jiang W; Lei T; Shu K
BMC Neurol; 2021 May; 21(1):190. PubMed ID: 33975554
[TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics, Surgical Outcomes, and Prognostic Factors of Intracranial Primary Central Nervous System Lymphoma.
Ouyang T; Wang L; Zhang N; Zhang Z; Xiong Y; Li M; Hong T
World Neurosurg; 2020 Jul; 139():e508-e516. PubMed ID: 32311566
[TBL] [Abstract][Full Text] [Related]
5. Surgery plus adjuvant radiotherapy for primary central nervous system lymphoma.
Kinslow CJ; Rae AI; Neugut AI; Adams CM; Cheng SK; Sheth SA; McKhann GM; Sisti MB; Bruce JN; Iwamoto FM; Sonabend AM; Wang TJC
Br J Neurosurg; 2020 Dec; 34(6):690-696. PubMed ID: 31931632
[No Abstract] [Full Text] [Related]
6. The role of whole-brain radiotherapy (WBRT) in primary central nervous system lymphoma: is it an alternative to ASCT for consolidation following HD-methotrexate based induction in low-income settings?
de Pádua Covas Lage LA; Araújo Soares V; Meneguin TD; Culler HF; Reichert CO; Jacomassi MD; Reis DGC; Zerbini MCN; de Oliveira Costa R; Rocha V; Pereira J
Radiat Oncol; 2022 Oct; 17(1):171. PubMed ID: 36273167
[TBL] [Abstract][Full Text] [Related]
7. Whether surgical resection or biopsy makes difference in single lesion primary central nervous system lymphoma: a single center retrospective cohort study.
Cheng X; Chen H; Sun C; Zhang B; Zhang J; Wang Y
BMC Neurol; 2022 Nov; 22(1):411. PubMed ID: 36333683
[TBL] [Abstract][Full Text] [Related]
8. Surgical resection versus biopsy in the treatment of primary central nervous system lymphoma: a systematic review and meta-analysis.
Chojak R; Koźba-Gosztyła M; Polańska K; Rojek M; Chojko A; Bogacz R; Skorupa N; Więcław J; Czapiga B
J Neurooncol; 2022 Dec; 160(3):753-761. PubMed ID: 36449256
[TBL] [Abstract][Full Text] [Related]
9. The role of comorbidity indices and histochemical markers in surgically resected and non-resected primary central nervous system lymphoma.
Wong CE; Liao WA; Chang Y; Lee PH; Huang CC; Chang KC; Lee JS
Clin Exp Med; 2023 Nov; 23(7):3799-3807. PubMed ID: 37491648
[TBL] [Abstract][Full Text] [Related]
10. Comparing the Efficacy of DeVIC Therapy and High-dose Methotrexate Monotherapy with Whole-brain Radiation Therapy for Newly-diagnosed Primary Central Nervous System Lymphoma: A Single Institution Study.
Chalise L; Motomura K; Ohka F; Hirano M; Hara M; Nishimura Y; Natsume A; Wakabayashi T
Anticancer Res; 2017 Sep; 37(9):5215-5223. PubMed ID: 28870957
[TBL] [Abstract][Full Text] [Related]
11. A Retrospective Analysis of R-MPV Plus Response-adapted Whole-brain Radiotherapy for Elderly Patients with Primary Central Nervous System Lymphoma.
Suzuki Y; Imoto N; Ishihara S; Fujiwara S; Ito R; Sakai T; Yamamoto S; Sugiura I; Kurahashi S
Intern Med; 2022 May; 61(9):1345-1352. PubMed ID: 34670884
[TBL] [Abstract][Full Text] [Related]
12. Clinical Outcomes of RTOG 9310 Protocol for Primary Central Nervous System Lymphoma: Single-Center Experience with 87 Patients.
Kim J; Kim TG; Lee HW; Kim SH; Park JE; Lee M; Kim YZ
Curr Oncol; 2021 Nov; 28(6):4655-4672. PubMed ID: 34898570
[TBL] [Abstract][Full Text] [Related]
13. Outcome of Primary Central Nervous System Lymphoma Treated with Combined Surgical Resection and High- Dose Methotrexate Chemotherapy: A Single-Institution Retrospective Study.
Zhang Q; Wang DW; Shu HS
Turk Neurosurg; 2022; 32(1):1-5. PubMed ID: 35018626
[TBL] [Abstract][Full Text] [Related]
14. The possible benefit from total tumour resection in primary diffuse large B-cell lymphoma of central nervous system - a one-decade single-centre experience.
Jelicic J; Todorovic Balint M; Raicevic S; Ilic R; Stanisavljevic D; Bila J; Antic D; Balint B; Andjelic B; Djurasinovic V; Sretenovic A; Vukovic V; Mihaljevic B
Br J Neurosurg; 2016; 30(1):80-5. PubMed ID: 26337736
[TBL] [Abstract][Full Text] [Related]
15. Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma.
Korfel A; Thiel E; Martus P; Möhle R; Griesinger F; Rauch M; Röth A; Hertenstein B; Fischer T; Hundsberger T; Mergenthaler HG; Junghanß C; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Roth P; Bamberg M; Pietsch T; Weller M
Neurology; 2015 Mar; 84(12):1242-8. PubMed ID: 25716362
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Key Factors Associated with Response to Salvage High-Dose Methotrexate Rechallenge in Primary Central Nervous System Lymphoma with First Relapse.
Du P; Chen H; Shen L; Liu X; Wu X; Chen L; Cao A; Geng D
Curr Oncol; 2022 Sep; 29(9):6642-6656. PubMed ID: 36135091
[TBL] [Abstract][Full Text] [Related]
17. High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.
Illerhaus G; Marks R; Ihorst G; Guttenberger R; Ostertag C; Derigs G; Frickhofen N; Feuerhake F; Volk B; Finke J
J Clin Oncol; 2006 Aug; 24(24):3865-70. PubMed ID: 16864853
[TBL] [Abstract][Full Text] [Related]
18. A prospective phase II trial of response adapted whole brain radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma-analysis of acute toxicity profile and early clinical outcome.
Adhikari N; Biswas A; Gogia A; Sahoo RK; Garg A; Nehra A; Sharma MC; Bhasker S; Singh M; Sreenivas V; Chawla R; Joshi G; Kumar L; Chander S
J Neurooncol; 2018 Aug; 139(1):153-166. PubMed ID: 29633112
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma.
Sun X; Liu J; Wang Y; Bai X; Chen Y; Qian J; Zhu H; Liu F; Qiu X; Sun S; Ji N; Liu Y
Oncotarget; 2017 Jul; 8(30):49156-49164. PubMed ID: 28467782
[TBL] [Abstract][Full Text] [Related]
20. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]